Nuclear Corepressors Mediate the Repression of Phospholipase A2 Group IIa Gene Transcription by Thyroid Hormone

作者: Pragya Sharma , Shalini Thakran , Xiong Deng , Marshall B. Elam , Edwards A. Park

DOI: 10.1074/JBC.M112.445569

关键词:

摘要: Secretory phospholipase A2 group IIa (PLA2g2a) is associated with inflammation, hyperlipidemia, and atherogenesis. Transcription of the PLA2g2a gene is induced by multiple cytokines. Here, we report the surprising observation that thyroid hormone (T3) inhibited PLA2g2a gene expression in human and rat hepatocytes as well as in rat liver. Moreover, T3 reduced the cytokine-mediated induction of PLA2g2a, suggesting that the thyroid status may modulate aspects of the inflammatory response. In an effort to dissect the mechanism of repression by T3, we cloned the PLA2g2a gene and identified a negative T3 response element in the promoter. This T3 receptor (TRβ)-binding site differed considerably from consensus T3 stimulatory elements. Using in vitro and in vivo binding assays, we found that TRβ bound directly to the PLA2g2a promoter as a heterodimer with the retinoid X receptor. Knockdown of nuclear corepressor or silencing mediator for retinoid and thyroid receptors by siRNA blocked the T3 inhibition of PLA2g2a. Using chromatin immunoprecipitation assays, we showed that nuclear corepressor and silencing mediator for retinoid and thyroid receptors were associated with the PLA2g2a gene in the presence of T3. In contrast with the established role of T3 to promote coactivator association with TRβ, our experiments demonstrate a novel inverse recruitment mechanism in which liganded TRβ recruits corepressors to inhibit PLA2g2a expression.

参考文章(71)
F E Wondisford, E A Farr, S Radovick, H J Steinfelder, J M Moates, J H McClaskey, B D Weintraub, Thyroid hormone inhibition of human thyrotropin β-subunit gene expression is mediated by a cis-acting element located in the first exon Journal of Biological Chemistry. ,vol. 264, pp. 14601- 14604 ,(1989) , 10.1016/S0021-9258(18)63736-6
H Wang, D C Harrison‐Shostak, J J Lemasters, B Herman, Contribution of pH‐dependent group II phospholipase A2 to chemical hypoxic injury in rat hepatocytes The FASEB Journal. ,vol. 10, pp. 1319- 1325 ,(1996) , 10.1096/FASEBJ.10.11.8836046
R M Crowl, T J Stoller, R R Conroy, C R Stoner, Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response Journal of Biological Chemistry. ,vol. 266, pp. 2647- 2651 ,(1991) , 10.1016/S0021-9258(18)52293-6
Tadashi Ikegami, Yasushi Matsuzaki, Sugano Fukushima, Junichi Shoda, Jean Luc Olivier, Bernard Bouscarel, Naomi Tanaka, Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells Hepatology. ,vol. 41, pp. 896- 905 ,(2005) , 10.1002/HEP.20630
Toshihiro Ichiki, Thyroid hormone and atherosclerosis. Vascular Pharmacology. ,vol. 52, pp. 151- 156 ,(2010) , 10.1016/J.VPH.2009.09.004
Koshi Hashimoto, Masanobu Yamada, Shunichi Matsumoto, Tsuyoshi Monden, Teturou Satoh, Masatomo Mori, Mouse Sterol Response Element Binding Protein-1c Gene Expression Is Negatively Regulated by Thyroid Hormone Endocrinology. ,vol. 147, pp. 4292- 4302 ,(2006) , 10.1210/EN.2006-0116
Mitchell A. Lazar, Thyroid hormone action: a binding contract. Journal of Clinical Investigation. ,vol. 112, pp. 497- 499 ,(2003) , 10.1172/JCI19479
Valérie ANTONIO, Arthur BROUILLET, Brigitte JANVIER, Claire MONNE, Gilbert BEREZIAT, Marise ANDREANI, Michel RAYMONDJEAN, Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors. Biochemical Journal. ,vol. 368, pp. 415- 424 ,(2002) , 10.1042/BJ20020658
Bo Angelin, Mats Rudling, Lipid lowering with thyroid hormone and thyromimetics Current Opinion in Lipidology. ,vol. 21, pp. 499- 506 ,(2010) , 10.1097/MOL.0B013E3283402E9C
DY Hui, MJ Cope, ED Labonté, H-T Chang, J Shao, E Goka, A Abousalham, D Charmot, J Buysse, The phospholipase A2 inhibitor methyl indoxam suppresses diet‐induced obesity and glucose intolerance in mice British Journal of Pharmacology. ,vol. 157, pp. 1263- 1269 ,(2009) , 10.1111/J.1476-5381.2009.00308.X